Cardio Diagnostics Holdings, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-6.5M | $-8.4M | $-8.4M | $-4.7M | $-620.4K |
| Depreciation & Amortization | $65.2K | $19.7K | $19.2K | $16.0K | $16.0K |
| Depreciation | $160.1K | $113.8K | $3.8K | $0 | — |
| Amortization | $5.3K | $16.0K | $16.0K | $16.0K | — |
| Stock-Based Compensation | $110.2K | $2.6M | $1.3M | $0 | $60.0K |
| Net Cash from Operating Activities | $-5.7M | $-5.0M | $-5.7M | $-5.1M | $-585.3K |
| Investing Activities | |||||
| Capital Expenditures | $187.3K | $214.8K | $575.7K | — | — |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-419.3K | $-404.2K | $-794.3K | $-368.0K | $-364.0K |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $3.4M | $11.9M | $3.6M | $9.1M | $1.2M |
| Net Change in Cash | — | — | — | — | — |
| Free Cash Flow | $-5.9M | $-5.2M | $-6.2M | — | — |